Monitoring & evaluation of national pharmacare – diabetes and contraception

Summary

Project ID: 2024-1182/ 2025 0970 405 000

Project title: Monitoring & evaluation of national pharmacare – diabetes and contraception

Principle Investigator: Canada’s Drug Agency (CDA)

Description: The goal of this work is to use health administrative data housed at HDRN’s provincial sites to quantify diabetes-related indicators and contraception indicators in four analytical domains – utilization, cost, outcomes, and resources – prior to and after the implementation of the Pharmacare Act.

PIA approved: January 3, 2024

Project status: In progress